Bristol Myers Squibb (BMS) and Pfizer are launching a new online portal to offer Eliquis directly to patients at a reduced price.
Starting September 8, uninsured and underinsured individuals can purchase the blood thinner for $346 per month through a direct-to-patient online program, Eliquis 360, down from the typical $606. The move follows a growing trend among pharmaceutical companies to improve affordability and streamline access through digital platforms.
With strong presences in Washington state, Bristol Myers Squibb and Pfizer exemplify how industry leaders are advancing equitable, patient-centered innovation.